Federal Judge Dismisses Biolase Lawsuit Against Fotona - CW Richmond WUPV |

Federal Judge Dismisses Biolase Lawsuit Against Fotona

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE The Fotona Companies

SAN CLEMENTE, Calif. and LJUBLJANA, Slovenia, June 11, 2014 /PRNewswire/ -- The Fotona companies, (Fotona), announced today, that on June 2, 2014, the federal judge in Orange County, California has dismissed all claims of Biolase's (BIOL) lawsuit against Fotona d.d. and Fotona LLC.  Among other things, Biolase had challenged Fotona's statements that its lasers were faster for hard tissue dental applications than Biolase's lasers. The Court concluded that Biolase has failed to state a claim for false advertising since Fotona's advertising statements are accurate restatements of conclusions in scientific journal articles. Fotona will continue to vigorously defend its products, and take action against false or misleading claims.


Fotona, celebrating 50 years of leadership in lasers, is a world-leading medical laser company recognized for its innovative, award-winning laser systems (http://www.fotona.com/en/about-us/news/?id=1202) for applications in aesthetics, dermatology, dentistry, surgery and gynecology. Based in the US and EU, Fotona's business philosophy is to continuously "choose perfection" to meet the needs of a highly demanding marketplace.  Strong R&D capabilities have always been a key competitive advantage of the company, resulting in many patented solutions. In addition to its direct presence in the US and EU, Fotona's global distribution network spans across more than 60 countries.

CONTACT: info@t4med.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WUPV. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service